QMed, Inc.
QMED
$0.0001
$0.000.00%
Weiss Ratings | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -77.86 | |||
Price History | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | -- | |||
60-Day Total Return | -- | |||
90-Day Total Return | -- | |||
Year to Date Total Return | -- | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -83.33% | |||
5-Year Total Return | 0.00% | |||
52-Week High % Change | 0.00% | |||
52-Week Low % Change | 0.00% | |||
Price | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.00 | |||
52-Week Low Price | $0.00 | |||
52-Week Low Price (Date) | Mar 24, 2025 | |||
52-Week High Price (Date) | Mar 24, 2025 | |||
Valuation | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 1.71K | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -- | |||
Earnings Per Share Growth | -- | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -- | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.00 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | -- | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 732-544-5544 | |||
Address | 25 Christopher Way Eatontown, NJ 07724 | |||
Website | www.qmedinc.com | |||
Country | United States | |||
Year Founded | 1983 | |||
Profitability | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -169.04% | |||
Profit Margin | -262.15% | |||
Management Effectiveness | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -29.94% | |||
Return on Equity | -- | |||
Income Statement | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 4.27M | |||
Total Revenue (TTM) | 4.27M | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | 1.93M | |||
EBITDA (TTM) | -6.74M | |||
EBIT (TTM) | -7.22M | |||
Net Income (TTM) | -11.19M | |||
Net Income Avl. to Common (TTM) | -11.19M | |||
Total Revenue Growth (Q YOY) | -56.51% | |||
Earnings Growth (Q YOY) | -481.13% | |||
EPS Diluted (TTM) | -0.66 | |||
EPS Diluted Growth (Q YOY) | -1.66% | |||
Balance Sheet | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 403.50K | |||
Cash Per Share (Q) | $0.02 | |||
Total Current Assets (Q) | 6.04M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 4.27M | |||
Current Ratio (Q) | 1.351 | |||
Book Value Per Share (Q) | -- | |||
Total Assets (Q) | -- | |||
Total Current Liabilities (Q) | 4.47M | |||
Total Debt (Q) | -- | |||
Total Liabilities (Q) | -- | |||
Total Common Equity (Q) | 4.27M | |||
Cash Flow | QMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 9.79M | |||
Cash from Financing (TTM) | 22.90K | |||
Net Change in Cash (TTM) | -1.55M | |||
Levered Free Cash Flow (TTM) | -6.74M | |||
Cash from Operations (TTM) | -11.36M | |||